Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delivra Health Brands Inc V.DHB

Alternate Symbol(s):  DHBUF

Healthcare Cannabis
Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. It has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.


TSXV:DHB - Post by User

Delivra Health Brands Inc
Bullboard Posts
User Avatar Image
(9)
•••
Comment by redrapson Feb 13, 2018 7:16am
77 Views
Post# 27549050

RE:RE:RE:RE:RE:RE:RE:RE:Future goals for HVT

RE:RE:RE:RE:RE:RE:RE:RE:Future goals for HVT

MMJ owns 57Million shares of HVT.  What % total is that?  I keep reading about the big boys buying them out but I am under the impression that MMJ (just purchased Dosecann - partners with EMC on special delivery methods) is going to grow this out.  Wouldnt the offer need to be very stong considering they have Two products in Clincal Trials phase 2 (epilepsy and MS) two more in Clinical trial phase 1? The product Satipharm is now waiting for HC approval on their other products, should get approval in Q1 2018.   I would love to see the sales of the GEL Pell after Q2 this year..

 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities